Articles
35 is the danger zone for hearts
We normally associate heart disease with old age. Doctors have been warning that the average age of first heart attacks has been coming down due...
Articles
DSCSA: The time has come to Act
Thierry Protas, Global Pharma Director at Videojet Technologies, looks at the importance of the Drug Supply Chain Security Act (DSCSA) legislation, the looming 2018 cut...
Articles
Quicker, More Accurate Diagnoses for Dangerous Diseases and Genetic Disorders
Standfirst:There is growing awareness of the valuable role that diagnostics can play, both in the early identification and treatment of dangerous or infectious diseases as...
Articles
Dash to Serialization Implementation: The European Falsified Medicines Directive (FMD) Countdown for Indian Pharma Manufacturers
Compliance is a serious issue for India’s pharmaceutical manufacturers, distributors, and retailers; due to the complicated nature of the pharmaceutical supply chain. Serialization requires pharmaceutical...
Articles
Looking Towards the Future: Worldwide Biosimilar Uptake and Pricing
What is a biosimilar?
Whereas generic drugs are identical copycats of small-molecule chemical products, biosimilars are only similar to biologic products; innately more complex than chemical...
Articles
Risking Addiction for Relief: Is There a Better Alternative to Opioids?
Every day, the United States loses 116 lives to the opioid epidemic.(1) Pharmacists are asking what can be done to combat the opioid epidemic and...
Articles
Commercial Pharma: It’s reboot time
CRM, CLM, KAM, Big Data, customer focus, patient centricity… for the last 20 years,buzzwords and concepts have been raining down on the Pharmaceutical Industry, generating...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.